Niagen Bioscience, Inc. (NAGE)

Niagen Bioscience Revenue

Niagen Bioscience had revenue of $27.19M in the quarter ending September 30, 2026, a decrease of -19.99%. This brings the company's total for the last twelve months to $122.29M, down -1.94% year-over-year. In the year 2025, Niagen Bioscience had annual revenue of $129.42M with 29.95% growth. That makes Niagen Bioscience the 21,167th largest company in the world by revenue and 3,162nd in the United States.

• Revenue (ttm): $122.29M
• Revenue Growth: -1.94%
• P/S Ratio: 1.34
• Revenue / Employee: $1,045,214
• Employees: 117
• Market Cap: 164.28M

Revenue Chart

Chart

Chart

Revenue by Segment

By Segment

Chart

• Consumer Products 97.67M 75.5%
• Ingredients 28.68M 22.2%
• Analytical Reference Standards and Services 3.08M 2.4%

By Geography

Chart

• United States 101.62M 78.5%
• International 27.80M 21.5%

Fiscal year ended Dec 31, 2025 See the full Niagen Bioscience breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	129.42M	29.83M	29.95%
Dec 31, 2024	99.60M	16.03M	19.18%
Dec 31, 2023	83.57M	11.52M	15.99%
Dec 31, 2022	72.05M	4.60M	6.82%
Dec 31, 2021	67.45M	8.19M	13.82%
Dec 31, 2020	59.26M	12.97M	28.01%
Dec 31, 2019	46.29M	14.73M	46.69%
Dec 31, 2018	31.56M	10.36M	48.85%
Dec 30, 2017	21.20M	-463.65K	-2.14%
Dec 31, 2016	21.66M	3.78M	21.13%
Jan 2, 2016	17.88M	2.57M	16.79%
Jan 3, 2015	15.31M	5.15M	50.71%
Dec 28, 2013	10.16M	-1.45M	-12.48%
Dec 29, 2012	11.61M	3.50M	43.12%
Dec 31, 2011	8.11M	546.24K	7.22%
Jan 1, 2011	7.57M	1.79M	30.95%
Jan 2, 2010	5.78M	1.27M	28.22%
Jan 3, 2009	4.51M	-247.77K	-5.21%
Dec 29, 2007	4.75M	-	-

Data Sources: Fiscal.ai and S&P Global Market Intelligence Last updated: Nov 4, 2026

Revenue data is provided by Fiscal.ai and updates within minutes after each earnings release, which is every three months for this company. Revenue segment and geography data is provided by S&P Global Market Intelligence.

Update frequency:

Quarterly

Last checked:

Nov 7, 2026

Data Sources Report a data error